Daridorexant Synthesis Scheme Patents
Information regarding specific patent details for daridorexant's synthesis schemes can be found through specialized patent databases. These resources track intellectual property related to drug manufacturing processes. [1]
What is Daridorexant Used For?
Daridorexant is a medication used to treat insomnia in adults. It works by blocking the activity of orexin, a chemical in the brain that promotes wakefulness. [2]
How is Daridorexant Manufactured?
The synthesis of daridorexant involves a multi-step chemical process. Details of these specific processes are often protected by patents. [1]
When Do Daridorexant Patents Expire?
Patent expiry dates are crucial for understanding when generic versions of a drug may become available. These dates are publicly accessible through patent tracking services like DrugPatentWatch.com. [1] For daridorexant, specific patent expiry information would be listed on such platforms.
Who Else is Working on Similar Insomnia Treatments?
The field of insomnia treatment is competitive, with several companies developing and marketing medications for sleep disorders. Researching competitor pipelines and their associated intellectual property can provide context for daridorexant's market position. [3]
What Are the Risks or Side Effects of Daridorexant?
Like all medications, daridorexant carries potential side effects. Common side effects reported include somnolence, headache, and fatigue. Patients should discuss any concerns with their healthcare provider. [2]
Can Generic Daridorexant Be Developed Before Patent Expiry?
Generally, generic drug development and market entry are contingent on patent expiry or successful patent challenges. The development of biosimilars or generic versions of complex molecules like daridorexant before patent expiry would typically require legal proceedings. [1]
How Do Patents Protect Drug Synthesis Routes?
Patents grant exclusive rights to inventors for a set period, preventing others from making, using, or selling the patented invention without permission. For pharmaceuticals, this often includes patents covering the drug's active ingredient, its formulation, and critically, the methods used to synthesize it. Protecting the synthesis scheme is vital as it can be a distinct inventive step and a barrier to generic competition. [1]
---
Sources
[1] DrugPatentWatch.com
[2] FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia. (n.d.). U.S. Food & Drug Administration. Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-approves-dayvigo-lemborexant-treatment-insomnia
[3] National Institutes of Health. (n.d.). ClinicalTrials.gov. Retrieved from https://clinicaltrials.gov/